In the 80s, human euglycemic-insulin clamp studies demonstrated that glycogen synthesis is the main non-oxidative pathway that follows the absorbed glucose in SM in normal subjects (DeFronzo et al., 1981), which was later confirmed and demonstrated to also occur in T2D (Shulman, et al., 1990). This evidence concerns the gene INS and type 2 diabetes mellitus.